You are here

Article info

Article menu
Download PDFPDF
BAS/BSCR Poster Abstracts
10 Certolizumab pegol inhibits tumour necrosis factor-induced endothelial cell activation

Authors

  • S K Heathfield Arthritis Research UK Epidemiology Unit, School of Translational Medicine, Faculty of Medical and Human Sciences, University of Manchester, Manchester, UKCardiovascular Research Group, School of Biomedicine, Faculty of Medical and Human Sciences, University of Manchester, Manchester, UK PubMed articlesGoogle scholar articles
  • I Bruce Arthritis Research UK Epidemiology Unit, School of Translational Medicine, Faculty of Medical and Human Sciences, University of Manchester, Manchester, UK PubMed articlesGoogle scholar articles
  • M Y Alexander Cardiovascular Research Group, School of Biomedicine, Faculty of Medical and Human Sciences, University of Manchester, Manchester, UK PubMed articlesGoogle scholar articles

Citation

Heathfield SK, Bruce I, Alexander MY
10 Certolizumab pegol inhibits tumour necrosis factor-induced endothelial cell activation
Heart 2011;97:e7.

Publication history

  • First published September 23, 2011.
Online issue publication 
November 23, 2015

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© 2011, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.